BioCorRx (BICX)
BioCorRx on one page: short interest, fails to deliver and insider trades. Listed on OTC, classified by the SEC as services-specialty outpatient facilities, nec.
10K
Short interest
settlement 2026-10-15
4.3
Days to cover
-7.4 days vs prior
25
Fails to deliver
settlement 2026-09-17
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-15.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in BICX is 9,927 shares, down 156 shares over the last month. Over the last 48 readings it ranged from 12 shares (14 November 2025) to 18,093 shares (31 August 2026). At the reported average volume of 2K shares a day that is 4.3 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/bicx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 9,927 | -5.6% | 2,291 | 4.33 |
| 2026-09-30 | 10,513 | +4.3% | 896 | 11.73 |
| 2026-09-15 | 10,083 | -44.3% | 2,494 | 4.04 |
| 2026-08-31 | 18,093 | +100.0% | 8,509 | 2.13 |
| 2026-07-31 | 543 | -68.8% | 15,973 | 1.00 |
| 2026-07-15 | 1,741 | +100.0% | 3,240 | 1.00 |
| 2026-05-15 | 8,304 | -23.7% | 5,980 | 1.39 |
| 2026-04-30 | 10,888 | -6.3% | 1,260 | 8.64 |
| 2026-04-15 | 11,625 | -0.8% | 91 | 127.75 |
| 2026-03-31 | 11,725 | -0.2% | 134 | 87.50 |
| 2026-03-13 | 11,751 | +173.7% | 4,814 | 2.44 |
| 2026-02-27 | 4,294 | +1526.5% | 5,322 | 1.00 |
| 2026-02-13 | 264 | +1785.7% | 25,861 | 1.00 |
| 2026-01-30 | 14 | -99.4% | 1,852 | 1.00 |
| 2026-01-15 | 2,430 | +20150.0% | 20,214 | 1.00 |
| 2025-12-31 | 12 | +0.0% | 2,905 | 1.00 |
| 2025-12-15 | 12 | +0.0% | 1,876 | 1.00 |
| 2025-11-28 | 12 | +0.0% | 1,426 | 1.00 |
| 2025-11-14 | 12 | +100.0% | 663 | 1.00 |
| 2025-10-15 | 60 | +100.0% | 921 | 1.00 |
| 2025-09-15 | 4,290 | +0.0% | 1,252 | 3.43 |
| 2025-08-29 | 4,290 | +0.0% | 850 | 5.05 |
| 2025-08-15 | 4,290 | -2.5% | 396 | 10.83 |
| 2025-07-31 | 4,398 | -0.4% | 1,615 | 2.72 |
| 2025-07-15 | 4,414 | +0.0% | 1,363 | 3.24 |
| 2025-06-30 | 4,414 | -0.1% | 478 | 9.23 |
| 2025-06-13 | 4,418 | -0.7% | 1,222 | 3.62 |
| 2025-05-30 | 4,448 | -1.2% | 5,179 | 1.00 |
| 2025-05-15 | 4,502 | -0.4% | 291 | 15.47 |
| 2025-04-30 | 4,519 | -1.6% | 214 | 21.12 |
| 2025-04-15 | 4,595 | -47.8% | 3,683 | 1.25 |
| 2025-03-31 | 8,806 | +23.8% | 7,149 | 1.23 |
| 2025-03-14 | 7,113 | +223.9% | 10,632 | 1.00 |
| 2025-02-28 | 2,196 | -3.9% | 66 | 33.27 |
| 2025-02-14 | 2,286 | +3.4% | 1,719 | 1.33 |
| 2025-01-31 | 2,210 | +100.0% | 49,060 | 1.00 |
| 2024-11-29 | 2,266 | +100.0% | 156 | 14.53 |
| 2024-09-13 | 405 | -30.9% | 916 | 1.00 |
| 2024-08-30 | 586 | +0.0% | 480 | 1.22 |
| 2024-08-15 | 586 | +100.0% | 4,997 | 1.00 |
| 2024-04-15 | 790 | +90.4% | 2,837 | 1.00 |
| 2024-03-28 | 415 | +0.0% | 1,897 | 1.00 |
| 2024-03-15 | 415 | -32.5% | 1,387 | 1.00 |
| 2024-02-29 | 615 | -1.8% | 2,988 | 1.00 |
| 2024-02-15 | 626 | +0.0% | 702 | 1.00 |
| 2024-01-31 | 626 | +0.0% | 1,565 | 1.00 |
| 2023-12-29 | 626 | -20.9% | 5,552 | 1.00 |
| 2023-12-15 | 791 | +100.0% | 4,083 | 1.00 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 17 September 2026, the fails-to-deliver balance in BICX is 25 shares, down 1,471 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (14 December 2023) to 10,440 shares (12 November 2024). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-17 | 25 | $0.25 | $6 |
| 2026-02-17 | 1,496 | $0.30 | $449 |
| 2026-01-16 | 2,281 | $0.33 | $753 |
| 2026-01-15 | 2,282 | $0.28 | $639 |
| 2025-10-02 | 1,900 | $0.21 | $399 |
| 2025-10-01 | 1,900 | $0.21 | $399 |
| 2025-09-30 | 1,900 | $0.50 | $950 |
| 2025-05-09 | 25 | $0.29 | $7 |
| 2024-11-12 | 10,440 | $0.31 | $3K |
| 2024-04-22 | 81 | $1.47 | $119 |
| 2024-04-19 | 85 | $1.47 | $125 |
| 2024-04-18 | 85 | $1.47 | $125 |
| 2024-04-15 | 675 | $1.50 | $1K |
| 2024-04-12 | 442 | $1.13 | $499 |
| 2024-04-11 | 442 | $1.50 | $663 |
| 2023-12-14 | 1 | $1.00 | $1 |
| 2023-07-24 | 130 | $2.04 | $265 |
| 2023-07-21 | 137 | $1.64 | $225 |
| 2023-07-20 | 137 | $2.22 | $304 |
| 2023-07-14 | 44 | $1.86 | $82 |
| 2023-07-13 | 54 | $2.00 | $108 |
| 2023-02-24 | 684 | $2.00 | $1K |
| 2023-02-23 | 713 | $2.00 | $1K |
| 2023-02-10 | 79 | $1.62 | $128 |
| 2023-02-09 | 651 | $1.68 | $1K |
| 2023-02-08 | 651 | $1.62 | $1K |
| 2023-02-07 | 451 | $1.62 | $731 |
| 2022-12-21 | 300 | $1.00 | $300 |
| 2022-12-20 | 100 | $1.10 | $110 |
| 2022-11-07 | 533 | $1.99 | $1K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for BICX in the last 90 days. The most recent filings are listed below. Latest filing: Felix Lourdes (CEO and CFO) on 2024-12-31.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | Felix Lourdes | CEO and CFO | Grant | 13K | $0.00 | $0 | 844K |
| 2024-12-31 | Lucido Louis C. | President | Grant | 13K | $0.00 | $0 | 2.5M |
| 2024-12-31 | Lucido Louis C. | President | Grant | 44K | $0.00 | $0 | 2.5M |
| 2024-11-29 | Lucido Louis C. | President | Grant | 55K | $0.00 | $0 | 2.5M |
| 2024-10-31 | Lucido Louis C. | President | Grant | 56K | $0.00 | $0 | 2.4M |
| 2024-10-14 | Lucido Louis C. | President | Grant | 1.1M | $0.00 | $0 | 2.3M |
| 2024-09-30 | Felix Lourdes | CEO and CFO | Grant | 16K | $0.00 | $0 | 830K |
| 2024-09-30 | Lucido Louis C. | President | Grant | 52K | $0.00 | $0 | 1.2M |
| 2024-09-30 | Lucido Louis C. | President | Grant | 16K | $0.00 | $0 | 1.2M |
| 2024-08-30 | Lucido Louis C. | President | Grant | 56K | $0.00 | $0 | 1.2M |
| 2024-07-31 | Lucido Louis C. | President | Grant | 32K | $0.00 | $0 | 1.1M |
| 2024-07-02 | Felix Lourdes | CEO and CFO | Grant | 500K | $0.00 | $0 | 815K |
| 2024-06-28 | Felix Lourdes | CEO and CFO | Grant | 10K | $0.00 | $0 | 91K |
| 2024-06-28 | Ingargiola Luisa | Director | Grant | 10K | $0.00 | $0 | 64K |
| 2024-06-28 | Lucido Louis C. | President | Grant | 34K | $0.00 | $0 | 623K |
| 2024-06-28 | Lucido Louis C. | President | Grant | 10K | $0.00 | $0 | 589K |
| 2024-05-31 | Lucido Louis C. | President | Grant | 23K | $0.00 | $0 | 579K |
| 2024-04-30 | Lucido Louis C. | President | Grant | 22K | $0.00 | $0 | 556K |
| 2024-04-24 | Felix Lourdes | CEO and CFO | Grant | 224K | $0.00 | $0 | 315K |
| 2024-04-24 | Lucido Louis C. | President | Other transaction | 460K | $0.00 | $0 | 1.1M |
| 2024-03-28 | Ingargiola Luisa | Director | Grant | 6K | $0.00 | $0 | 54K |
| 2024-03-28 | Felix Lourdes | CEO and CFO | Grant | 6K | $0.00 | $0 | 80K |
| 2024-03-28 | Lucido Louis C. | President | Grant | 19K | $0.00 | $0 | 534K |
| 2024-03-28 | Lucido Louis C. | President | Grant | 6K | $0.00 | $0 | 516K |
| 2024-03-28 | Murthy Harsha | Director | Grant | 6K | $0.00 | $0 | 20K |
| 2024-03-28 | GALLIGAN JOSEPH J | Director,TenPercentOwner | Grant | 6K | $0.00 | $0 | 238K |
| 2024-02-29 | Lucido Louis C. | President | Grant | 17K | $0.00 | $0 | 510K |
| 2024-01-31 | Lucido Louis C. | President | Grant | 18K | $0.00 | $0 | 493K |
| 2024-01-16 | Lucido Louis C. | Interim President | Buy | 126 | $0.70 | $88 | 475K |
| 2024-01-12 | Lucido Louis C. | Interim President | Buy | 3K | $0.70 | $2K | 475K |
| 2024-01-02 | Murthy Harsha | Director | Grant | 6K | $0.00 | $0 | 14K |
| 2024-01-02 | GALLIGAN JOSEPH J | Director,TenPercentOwner | Grant | 6K | $0.00 | $0 | 232K |
| 2024-01-02 | Ingargiola Luisa | Director | Grant | 6K | $0.00 | $0 | 48K |
| 2024-01-02 | Lucido Louis C. | Director,TenPercentOwner | Grant | 6K | $0.00 | $0 | 472K |
| 2024-01-02 | Felix Lourdes | CEO and CFO | Grant | 6K | $0.00 | $0 | 75K |
| 2023-09-29 | Felix Lourdes | CEO and CFO | Grant | 3K | $0.00 | $0 | 69K |
| 2023-09-29 | Lucido Louis C. | Director,TenPercentOwner | Grant | 3K | $0.00 | $0 | 466K |
| 2023-09-29 | Ingargiola Luisa | Director | Grant | 3K | $0.00 | $0 | 42K |
| 2023-09-29 | Murthy Harsha | Director | Grant | 3K | $0.00 | $0 | 8K |
| 2023-09-29 | GALLIGAN JOSEPH J | Director,TenPercentOwner | Grant | 3K | $0.00 | $0 | 226K |
| 2023-09-29 | Emry Kent | Director | Grant | 3K | $0.00 | $0 | 114K |
| 2023-06-30 | Felix Lourdes | CEO and CFO | Grant | 3K | $0.00 | $0 | 66K |
| 2023-06-30 | Lucido Louis C. | Director,TenPercentOwner | Grant | 3K | $0.00 | $0 | 463K |
| 2023-06-30 | Ingargiola Luisa | Director | Grant | 3K | $0.00 | $0 | 39K |
| 2023-06-30 | Murthy Harsha | Director | Grant | 3K | $0.00 | $0 | 5K |
| 2023-06-30 | Emry Kent | Director | Grant | 3K | $0.00 | $0 | 111K |
| 2023-06-30 | GALLIGAN JOSEPH J | Director,TenPercentOwner | Grant | 3K | $0.00 | $0 | 223K |
| 2023-04-03 | Lucido Louis C. | Director,TenPercentOwner | Other transaction | 184K | $0.00 | $0 | 460K |
| 2023-04-03 | Lucido Louis C. | Director,TenPercentOwner | Buy | 171K | $1.75 | $300K | 276K |
| 2023-03-31 | Emry Kent | Director | Grant | 3K | $0.00 | $0 | 108K |
| 2023-03-31 | GALLIGAN JOSEPH J | Director,TenPercentOwner | Grant | 3K | $0.00 | $0 | 220K |
| 2023-03-31 | Felix Lourdes | CEO and CFO | Grant | 3K | $0.00 | $0 | 63K |
| 2023-03-31 | Lucido Louis C. | Director,TenPercentOwner | Grant | 3K | $0.00 | $0 | 105K |
| 2023-03-31 | Ingargiola Luisa | Director | Grant | 3K | $0.00 | $0 | 36K |
| 2023-03-31 | Murthy Harsha | Director | Grant | 2K | $0.00 | $0 | 2K |
| 2023-03-29 | GALLIGAN JOSEPH J | Director,TenPercentOwner | Buy | 171K | $1.75 | $300K | 218K |
| 2023-01-30 | Lucido Louis C. | Director,TenPercentOwner | Buy | 300 | $1.39 | $417 | 102K |
| 2023-01-30 | Lucido Louis C. | Director,TenPercentOwner | Buy | 100 | $1.37 | $137 | 102K |
| 2023-01-26 | Lucido Louis C. | Director,TenPercentOwner | Buy | 500 | $1.29 | $645 | 102K |
| 2023-01-24 | Lucido Louis C. | Director,TenPercentOwner | Buy | 200 | $1.20 | $240 | 101K |
| 2023-01-13 | Lucido Louis C. | Director, 10% owner | Buy | 2K | $1.10 | $2K | 99K |
| 2023-01-13 | Lucido Louis C. | Director,TenPercentOwner | Buy | 2K | $1.15 | $2K | 101K |
| 2023-01-03 | Lucido Louis C. | Director,TenPercentOwner | Buy | 2K | $1.10 | $2K | 97K |
| 2022-12-30 | GALLIGAN JOSEPH J | Director,TenPercentOwner | Grant | 5K | $0.00 | $0 | 46K |
| 2022-12-30 | Felix Lourdes | CEO and CFO | Grant | 5K | $0.00 | $0 | 60K |
| 2022-12-30 | Lucido Louis C. | Director,TenPercentOwner | Buy | 200 | $0.98 | $196 | 90K |
| 2022-12-30 | Lucido Louis C. | Director,TenPercentOwner | Grant | 5K | $0.00 | $0 | 95K |
| 2022-12-30 | Lucido Louis C. | Director,TenPercentOwner | Buy | 115 | $1.03 | $118 | 90K |
| 2022-12-30 | Emry Kent | Director | Grant | 5K | $0.00 | $0 | 105K |
| 2022-12-30 | Ingargiola Luisa | Director | Grant | 5K | $0.00 | $0 | 34K |
| 2022-12-12 | Lucido Louis C. | Director, 10% owner | Buy | 1K | $0.80 | $800 | 87K |
| 2022-12-12 | Lucido Louis C. | Director, 10% owner | Buy | 1K | $0.98 | $980 | 86K |
| 2022-12-12 | Lucido Louis C. | Director,TenPercentOwner | Buy | 2K | $0.80 | $2K | 89K |
| 2022-12-12 | Lucido Louis C. | Director,TenPercentOwner | Buy | 1K | $0.79 | $790 | 85K |
| 2022-10-06 | Lucido Louis C. | Director,TenPercentOwner | Buy | 360 | $1.90 | $684 | 84K |
| 2022-10-06 | Lucido Louis C. | Director,TenPercentOwner | Buy | 120 | $1.90 | $228 | 84K |
| 2022-10-06 | Lucido Louis C. | Director,TenPercentOwner | Buy | 100 | $1.73 | $173 | 84K |
| 2022-10-05 | Lucido Louis C. | Director,TenPercentOwner | Buy | 1K | $2.02 | $2K | 84K |
| 2022-09-30 | GALLIGAN JOSEPH J | Director,TenPercentOwner | Grant | 2K | $0.00 | $0 | 41K |
| 2022-09-30 | Emry Kent | Director | Grant | 2K | $0.00 | $0 | 100K |
| 2022-09-30 | Felix Lourdes | CEO and CFO | Grant | 2K | $0.00 | $0 | 55K |
| 2022-09-30 | Ingargiola Luisa | Director | Grant | 2K | $0.00 | $0 | 28K |
| 2022-09-30 | Lucido Louis C. | Director,TenPercentOwner | Grant | 2K | $0.00 | $0 | 83K |
| 2022-09-06 | Lucido Louis C. | Director,TenPercentOwner | Buy | 10 | $2.10 | $21 | 83K |
| 2022-08-31 | Lucido Louis C. | Director,TenPercentOwner | Buy | 610 | $2.12 | $1K | 80K |
| 2022-08-29 | Lucido Louis C. | Director,TenPercentOwner | Buy | 1K | $2.12 | $2K | 78K |
| 2022-08-29 | Lucido Louis C. | Director,TenPercentOwner | Buy | 2K | $2.10 | $5K | 80K |
| 2022-08-26 | Lucido Louis C. | Director,TenPercentOwner | Buy | 560 | $2.12 | $1K | 77K |
| 2022-08-25 | Lucido Louis C. | Director,TenPercentOwner | Buy | 500 | $2.18 | $1K | 76K |
| 2022-06-30 | Emry Kent | Director | Grant | 2K | $0.00 | $0 | 98K |
| 2022-06-30 | Ingargiola Luisa | Director | Grant | 2K | $0.00 | $0 | 26K |
| 2022-06-30 | Felix Lourdes | CEO and CFO | Grant | 2K | $0.00 | $0 | 52K |
| 2022-06-30 | Lucido Louis C. | Director,TenPercentOwner | Grant | 2K | $0.00 | $0 | 75K |
| 2022-06-30 | GALLIGAN JOSEPH J | Director,TenPercentOwner | Grant | 2K | $0.00 | $0 | 38K |
| 2022-03-31 | Ingargiola Luisa | Director | Grant | 1K | $0.00 | $0 | 25K |
| 2022-03-31 | Felix Lourdes | CEO and CFO | Grant | 1K | $0.00 | $0 | 50K |
| 2022-03-31 | Emry Kent | Director | Grant | 1K | $0.00 | $0 | 96K |
| 2022-03-31 | Lucido Louis C. | Director,TenPercentOwner | Grant | 1K | $0.00 | $0 | 73K |
| 2022-03-31 | GALLIGAN JOSEPH J | Director,TenPercentOwner | Grant | 1K | $0.00 | $0 | 38K |
| 2021-12-31 | Ingargiola Luisa | Director | Grant | 1K | $0.00 | $0 | 24K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
What this page is
BioCorRx in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows BioCorRx (BICX), SEC CIK 1443863, listed on OTC, classified by the SEC as services-specialty outpatient facilities, nec. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-17.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2024-12-31.JSON and CSV
- Company record
- EDGAR filing index for CIK 1443863Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-specialty outpatient facilities, nec
Other company pages
- TKOTKO Group Holdings
- TLNTalen Energy
- TMOThermo Fisher Scientific
- TMUST-Mobile US
- TNONTenon Medical
- TOLToll Brothers
- TOSTToast
- TPGTPG
- TPLTexas Pacific Land
- TPRTapestry
- TRGPTarga Resources
- TRIThomson Reuters
- TRMBTrimble
- TROWT. Rowe Price
- TRPTC Energy
- TRUTransUnion
- TRVTravelers Companies
- TSCOTractor Supply
- TSEMTower Semiconductor
- TSLATesla
- TSMTaiwan Semiconductor Manufacturing
- TSNTyson Foods
Datasets
Frequently Asked Questions
How much of BICX is sold short?
What is BICX's daily short volume?
Does BICX have fails to deliver?
Are BICX insiders buying or selling?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.